These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 33879910)

  • 21. Structure-function correlation and personalized 3D printed tablets using a quality by design (QbD) approach.
    Zhang J; Thakkar R; Zhang Y; Maniruzzaman M
    Int J Pharm; 2020 Nov; 590():119945. PubMed ID: 33027633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of 3D printing technology for generating hollow-type suppository shells.
    Tagami T; Ito E; Hayashi N; Sakai N; Ozeki T
    Int J Pharm; 2020 Nov; 589():119825. PubMed ID: 32861769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and fabrication of 3D-printed gastric floating tablets of captopril: effect of geometry and thermal crosslinking of polymer on floating behavior and drug release.
    Mohammed AA; Alqahtani AA; Ahmed MM
    Pharm Dev Technol; 2024 Jun; 29(5):517-529. PubMed ID: 38721970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
    Gültekin HE; Tort S; Acartürk F
    Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and Optimization of 3D-Printed Gastroretentive Floating Devices by Central Composite Design.
    Charoenying T; Patrojanasophon P; Ngawhirunpat T; Rojanarata T; Akkaramongkolporn P; Opanasopit P
    AAPS PharmSciTech; 2021 Jun; 22(5):197. PubMed ID: 34191172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3D Printed Intragastric Floating and Sustained-Release Tablets with Air Chambers.
    Zhao X; Wei W; Niu R; Li Q; Hu C; Jiang S
    J Pharm Sci; 2022 Jan; 111(1):116-123. PubMed ID: 34303671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
    Oladeji S; Mohylyuk V; Jones DS; Andrews GP
    Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and development of 3D-printed bento box model for controlled drug release of propranolol HCl following pharmacopeia dissolution guidelines.
    Kraisit P; Limpamanoch P; Hirun N; Limmatvapirat S
    Int J Pharm; 2022 Nov; 628():122272. PubMed ID: 36220589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Intragastric Delivery Device Employing FDM Technology: 3D-Printed Tablet Containing Green Developed Mosapride-Saccharin Co-crystals.
    Amin OM; El Qady HN; Abd El-Fattah MA
    AAPS PharmSciTech; 2023 Jun; 24(5):127. PubMed ID: 37264247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
    Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
    J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development and optimisation of gastro-retentive floating tablets using fused deposition modelling 3D printing.
    Oladeji SA; Dadou SM; Zhao M; Li S; Jones DS; Andrews GP
    J Pharm Pharmacol; 2022 Oct; 74(10):1450-1466. PubMed ID: 35253894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fabrication of Zero-Order Sustained-Release Floating Tablets via Fused Depositing Modeling 3D Printer.
    Kimura SI; Ishikawa T; Iwao Y; Itai S; Kondo H
    Chem Pharm Bull (Tokyo); 2019; 67(9):992-999. PubMed ID: 31474738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Customized Novel Design of 3D Printed Pregabalin Tablets for Intra-Gastric Floating and Controlled Release Using Fused Deposition Modeling.
    Lamichhane S; Park JB; Sohn DH; Lee S
    Pharmaceutics; 2019 Oct; 11(11):. PubMed ID: 31671686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
    Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
    Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evaluation of the effect of different superdisintegrants on the drug release from FDM 3D printed tablets through different applied strategies: In vitro-in silico assessment.
    Đuranović M; Madžarević M; Ivković B; Ibrić S; Cvijić S
    Int J Pharm; 2021 Dec; 610():121194. PubMed ID: 34728321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
    Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tailoring immediate release FDM 3D printed tablets using a quality by design (QbD) approach.
    Than YM; Titapiwatanakun V
    Int J Pharm; 2021 Apr; 599():120402. PubMed ID: 33640426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.